Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA, Bouillon R, et al. Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev. 2017;97:135–87.

Article  PubMed  Google Scholar 

Malgo F, Appelman-Dijkstra NM, Termaat MF, van der Heide HJL, Schipper IB, Rabelink TJ, et al. High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD. Arch Osteoporos. 2016;11:12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansz TT, Goto NA, van Ballegooijen AJ, Willems HC, Verhaar MC, van Jaarsveld BC. The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2020;31:515–24.

Article  CAS  Google Scholar 

Mahzari MM, Alibrahim AR, Alghamdi NA, Alsadhan MA, Almoamary SM, Masuadi EM, et al. Prevalence and Risk Factors of Osteoporosis in Saudi End-Stage Renal Disease Patients on Hemodialysis. Saudi J Med Med Sci. 2022;10:259–65.

Article  PubMed  PubMed Central  Google Scholar 

Hu X, Ye X, Chen H, Wu B, Guo Q, Yu C, et al. Depression as a risk factor for osteoporosis independent of sarcopenia in hemodialysis patients: findings from a multicenter cross-sectional study. BMC Nephrol. 2025;26:35.

Article  PubMed  PubMed Central  Google Scholar 

Vilaca T, Salam S, Schini M, Harnan S, Sutton A, Poku E, et al. Risks of Hip and Nonvertebral Fractures in Patients With CKD G3a–G5D: A Systematic Review and Meta-analysis. Am J Kidney Dis Off J Natl Kidney Found. 2020;76:521–32.

Article  Google Scholar 

Xie L, Hu X, Li W, Ouyang Z. A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures. BMC Nephrol. 2021;22:23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang YS, Kim H, Kim SY, Park YS, Yun I, Park E-C, et al. Effect of chronic kidney disease on all-cause mortality after hip fracture surgery: A retrospective cohort study. Calcif Tissue Int. 2024;

Hansen D, Jørgensen HS, Andersen TL, Ferreira AC, Ferreira A, de Jongh R, et al. Multidisciplinary team approach for CKD-associated osteoporosis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2024;gfae197.

Hsu C-T, Deng Y-L, Chung M-C, Tsai S-F, Lin S-Y, Chen C-H. Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease. Healthc Basel Switz. 2023;11:313.

Google Scholar 

Van Camp L, Dejaeger M, Tournoy J, Gielen E, Laurent MR. Association of orthogeriatric care models with evaluation and treatment of osteoporosis: a systematic review and meta-analysis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2020;31:2083–92.

Article  Google Scholar 

Bover J, Gómez-Alonso C, Casado E, Rodríguez-García M, Lloret MJ, Castro-Alonso C, et al. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care. Nefrologia. 2024;44:241–50.

Article  PubMed  Google Scholar 

Khairallah P, Nickolas TL. Updates in CKD-Associated Osteoporosis. Curr Osteoporos Rep. 2018;16:712–23.

Article  PubMed  PubMed Central  Google Scholar 

Miller PD, Adachi JD, Albergaria B-H, Cheung AM, Chines AA, Gielen E, et al. Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease. J Bone Miner Res Off J Am Soc Bone Miner Res. 2022;37:1437–45.

Article  CAS  Google Scholar 

Hara T, Hijikata Y, Matsubara Y, Watanabe N. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3–5D. Cochrane Database Syst Rev. 2021;7:CD013424.

Fixen CW, Fixen DR. Renal safety of zoledronic acid for osteoporosis in adults 75 years and older. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2022;33:2417–22.

Article  CAS  Google Scholar 

Sabaghian T, Delkash P, Rahmannia M, Shahidi Bonjar AH, Centis R, D’Ambrosio L, et al. Efficacy and safety of anti-osteoporotic agents across CKD Stages: A meta-analysis of randomized clinical trials. Kidney Blood Press Res. 2024;49:581–7.

PubMed  Google Scholar 

Robinson DE, Ali MS, Pallares N, Tebé C, Elhussein L, Abrahamsen B, et al. Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: A binational cohort analysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2021;36:820–32.

Article  CAS  Google Scholar 

Oda T, Jödicke AM, Robinson DE, Delmestri A, Keogh RH, Prieto-Alhambra D. Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: A self-controlled case series in the United Kingdom. J Bone Miner Res Off J Am Soc Bone Miner Res. 2022;37:1270–8.

Article  CAS  Google Scholar 

Park C, Kim C, Park RW, Jeon JY. Comparative effectiveness and safety outcomes between denosumab and bisphosphonate in South Korea. J Bone Miner Res Off J Am Soc Bone Miner Res. 2024;39:835–43.

Article  Google Scholar 

Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust M-H, et al. European consensus statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2021;36:42–59.

CAS  Google Scholar 

Cejka D, Wakolbinger-Habel R, Zitt E, Fahrleitner-Pammer A, Amrein K, Dimai HP, et al. Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN). Wien Med Wochenschr. 1946;2023(173):299–318.

Google Scholar 

Kao C-C, Wu P-C, Chuang M-T, Yeh S-C, Lin Y-C, Chen H-H, et al. Effects of osteoporosis medications on bone fracture in patients with chronic kidney disease. Postgrad Med J. 2023;99:340–9.

Article  PubMed  Google Scholar 

Leng Y, Yu X, Yang Y, Xia Y. Efficacy and safety of medications for osteoporosis in kidney transplant recipients or patients with chronic kidney disease: A meta-analysis. J Investig Med Off Publ Am Fed Clin Res. 2023;71:760–72.

Google Scholar 

Wilson LM, Rebholz CM, Jirru E, Liu MC, Zhang A, Gayleard J, et al. Benefits and harms of osteoporosis medications in patients with chronic kidney disease: A systematic review and meta-analysis. Ann Intern Med. 2017;166:649–58.

Article  PubMed  Google Scholar 

Jørgensen HS, Lloret MJ, Lalayiannis AD, Shroff R, Evenepoel P, European Renal Osteodystrophy (EUROD) initiative of the CKD-MBD working group of the European Renal Association (ERA), and the CKD-MBD and Dialysis working groups of the European Society of Pediatric Nephrology. Ten tips on how to assess bone health in patients with chronic kidney disease. Clin Kidney J. 2024;17:sfae093.

Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust M-H, et al. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2021;32:2397–405.

Article  CAS  Google Scholar 

Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945–53.

Article  CAS  PubMed  Google Scholar 

Elkhouli E, Nagy E, Santos CGS, Barreto FC, Chaer J, Jorgetti V, et al. Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA. 2023;34:2003–12.

Article  Google Scholar 

Brandenburg VM, Floege J. Adynamic bone disease-bone and beyond. NDT Plus. 2008;1:135–47.

PubMed  PubMed Central  Google Scholar 

de Oliveira RB, Carvalho AB, Jorgetti V. Bone aluminum accumulation in the current era. J Bras Nefrol. 2024;46:e20240023.

PubMed  PubMed Central  Google Scholar 

Sotomayor CG, Benjamens S, Gomes-Neto AW, Pol RA, Groothof D, Te Velde-Keyzer CA, et al. Bone mineral density and aortic calcification: Evidence for a Bone-vascular axis after kidney transplantation. Transplantation. 2021;105:231–9.

Article  CAS  PubMed  Google Scholar 

Ahn SY, Ko GJ, Hwang HS, Jeong KH, Jin K, Kim YG, et al. Understanding the Korean dialysis cohort for mineral, vascular calcification, and fracture (ORCHESTRA) study: design, method, and baseline characteristics. Kidney Blood Press Res. 2024;49:326–35.

PubMed  Google Scholar 

Schousboe JT, Lewis JR, Monchka BA, Reid SB, Davidson MJ, Kimelman D, et al. Simultaneous automated ascertainment of prevalent vertebral fracture and abdominal aortic calcification in clinical practice: role in fracture risk assessment. J Bone Miner Res Off J Am Soc Bone Miner Res. 2024;zjae066.

Wei R, Zhang Y, Huang M, Piao H, Gu Z, Zhu C. Associations between bone mineral density and abdominal aortic calcification: Results of a nationwide survey. Nutr Metab Cardiovasc Dis NMCD. 2024;34:1488–95.

Article  CAS  PubMed  Google Scholar 

Szulc P, Lewis JR, Chapurlat R. Accelerated bone loss in older men with severe abdominal aortic calcification-the prospective MINOS Study. J Clin Endocrinol Metab. 2023;109:e32–9.

Article  PubMed  Google Scholar 

Eknoyan G, Moe SM. Renal osteodystrophy: A historical review of its origins and conceptual evolution. Bone Rep. 2022;17:101641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moe SM. Renal Osteodystrophy or kidney-induced osteoporosis? Curr Osteoporos Rep. 2017;15:194–7.

Article  PubMed  PubMed Central  Google Scholar 

Fusaro M, Re Sartò GV, Gallieni M, Cosmai L, Messa P, Rossini M, et al. Time for revival of bone biopsy with Histomorphometric analysis in chronic kidney disease (CKD): moving from skepticism to pragmatism. Nutrients. 2022;14:1742.